-
Commentary: There are a lot of innovative options that have been implemented by those who are being proactive and who are changing their roles as employee benefit advisers. Columnist Jack Kwicien shares their competitive advantage.
January 14
Daymark Advisors -
Commentary: In sales, theres often too much boasting and not enough doing. Sales expert John Graham shares seven steps to boost your bottom line.
January 13
GrahamComm -
Commentary: Plan sponsors should not only understand the importance and benefits of fiduciary roles in a sponsor plan, but also understand the positive impact a fiduciary can have, says columnist John Ludwig.
January 12
LHD Retirement -
Commentary: While agents providing these value-added services have disrupted the market and changed the nature of the benefit sales game, they were but a precursor to the far bigger disruptor taking over huge chunks of the benefits marketplace, says columnist Mel Schlesinger.
January 12
-
Commentary: Not holding producers accountable does immeasurable damage to your culture and morale, says columnist Wendy Keneipp, who shares how to build a plan to keep your producers productive today.
January 12
Q4intelligence -
Commentary: Benefit Advisors Networks Perry Braun outlines how a national agent and broker licensing process stands to impact advisers and other key stakeholders, including clients.
January 9
-
Commentary: How to win the game by exiting the technology arms race and saving money in the process. Tech expert Joe Markland shares 8 guiding principles.
January 8
Nfor1 -
Commentary: If you work with businesses that have high-income earners, you have an opportunity to sell IDI policies on a guarantee issue basis, which creates many advantages for the insureds, the employer and you.
December 31
-
Commentary: Benefit professionals still struggle to have a seat at the table with a companys big decision makers. Workplace expert Brad Karsh shares five tips on how to get the C-suite to take notice.
December 30
-
Commentary: Why employers need benefit advisers more than ever to fight rising generic drug prices.
December 29